NEOSTREPTAZA

This brand name is authorized in Poland

Active ingredients

The drug NEOSTREPTAZA contains a combination of these active pharmaceutical ingredients (APIs):

1 Streptokinase
UNII 8X1OXL3SNU - STREPTOKINASE

Biofactor streptokinase is a highly purified streptokinase derived from ฮฒ haemolytic streptococci of Lancefield group C. The activation of the endogenous fibrinolytic system is initiated by the formation of a streptokinase-plasminogen complex. This complex possesses activator properties and converts plasminogen into the proteolytic and fibrinolytic active plasmin.

Read about Streptokinase
2 Streptodornase
UNII DV8J2R3544 - STREPTODORNASE

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B06AA55 Streptokinase, combinations B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents → B06AA Enzymes
Discover more medicines within B06AA55

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: PL Rejestru Produktรณw Leczniczych Identifier(s): 100436390

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈